Expression of CD30 in testis and Epididymis of adult mice

References

• Amakawa , R , Hakem , A , Kundig , TM , Matsuyama , T , Simard , JJ , Timms , E , Wakeham , A , Mittruecker , HW , Griesser , H , Takimoto , H , Schmits , R , Shahinian , A , Ohashi , P , Penninger , JM and Mak , TW . 1996 . Impaired negative selection of T cells in Hodgkin's disease antigen CD30‐deficient mice . Cell , 84 : 551 – 562 .
   PubMed Web of Science ®Google Scholar
• Annunziato , F , Galli , G , Cosmi , L , Romagnani , P , Manetti , R , Maggi , E and Romagnani , S . 1998 . Molecules associated with human Th1 or Th2 cells . Eur Cytokine Netw , 9 : 12 – 16 .
   PubMed Web of Science ®Google Scholar
• Barth , S , Huhn , M , Matthey , B , Tawadros , S , Schnell , R , Schinkothe , T , Diehl , V and Engert , A . 2000 . Ki‐4(scFv)‐ETA’, a new recombinant anti‐CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice . Blood , 95 : 3909 – 3914 .
   PubMed Web of Science ®Google Scholar
• Bengtsson , A , Johansson , C , Linder , MT , Hallden , G , van der Ploeg , I and Scheynius , A . 1995 . Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation . Leukocyte Biol , 58 : 683 – 689 .
   PubMed Web of Science ®Google Scholar
• Boekelheide , K , Lee , J , Shipp , EB , Richburg , JH and Li , G . 1998 . Expression of Fas system‐related genes in the testis during development and after toxicant exposure . Toxicol Lett , 102 ( 103 ) : 503 – 508 .
   PubMedGoogle Scholar
• Chomczynski , P and Sacchi , N . 1987 . Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction . Ann Biochem , 162 : 156 – 159 .
   Web of Science ®Google Scholar
• D'Elios , MM , Romagnani , P , Scaletti , C , Annunziato , F , Manghetti , M , Mavilia , C , Parronchi , P , Pupilli , C , Pizzolo , G , Maggi , E , Del Prete , GF and Romagnani , S . 1997 . In vivo CD30 expression in human diseases with predominant activation of Th2‐like T cells . J Leukocyte Biol , 61 : 539 – 544 .
   PubMed Web of Science ®Google Scholar
• Durkop , H , Latza , U , Hummel , M , Eitelbach , F , Seed , B and Stein , H . 1992 . Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease . Cell , 68 : 421 – 427 .
   PubMed Web of Science ®Google Scholar
• Eddy , EM and O'Brien , DA . 1994 . “ The spermatozoon ” . In The Physiology of Reproduction , Edited by: Knovil , E and Neill , JD . 29 – 77 . New York : Raven Press .
   Google Scholar
• Ellis , TM , Simms , PE , Slivnick , DJ , Jack , HM and Fisher , RI . 1993 . CD30 is a signal‐transducing molecule that defines a subset of human activated CD45RO+ T cells . J Immunol , 151 : 2380 – 2389 .
   PubMed Web of Science ®Google Scholar
• Fawcett , DW . 2001 . The mammalian spermatozoon . Dev Biol , 44 : 394 – 436 .
   Google Scholar
• Graus , F , Cordon‐Cardo , C , Houghton , AN , Melamed , MR and Old , LJ . 1984 . Distribution of the ganglioside GD3 in the human nervous system detected by R24 mouse monoclonal antibody . Brain Res , 324 : 190 – 194 .
   PubMed Web of Science ®Google Scholar
• Gruss , HJ and Dower , SK . 1995 . Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas . Blood , 85 : 3378 – 3404 .
   PubMed Web of Science ®Google Scholar
• Gruss , HJ , Boiani , N , Williams , DE , Armitage , RJ , Smith , CA and Goodwin , RG . 1994a . Pleiotropic effects of the CD30 ligand on CD30‐expressing cells and lymphoma cell lines . Blood , 83 : 2045 – 2056 .
   PubMed Web of Science ®Google Scholar
• Gruss , HJ , DaSilva , N , Hu , ZB , Uphoff , CC , Goodwin , RG and Drexler , HG . 1994b . Expression and regulation of CD30 ligand and CD30 in human leukemia‐lymphoma cell lines . Leukemia , 8 : 2083 – 2094 .
   PubMed Web of Science ®Google Scholar
• Hamann , D , Hilkens , CM , Grogan , JL , Lens , SM , Kapsenberg , ML , Yazdanbakhsh , M and van Lier , RA . 1996 . CD30 expression does not discriminate between human Th1‐ and Th2‐type T cells . J Immunol , 156 : 1387 – 1391 .
   PubMed Web of Science ®Google Scholar
• Herbst , H , Stein , H and Niedobitek , G . 1993 . Epstein‐Barr virus and CD30+ malignant lymphomas . Crit Rev Oncolog , 4 : 191 – 239 .
   PubMed Web of Science ®Google Scholar
• Hodges , GF , Lenhardt , TM , Secord , AR , Rushin , JM and Cotelingam , JD . 1991 . CD30 antigen expression . Am J Clin Pathol , 95 : 103
   PubMedGoogle Scholar
• Jung , KY , Kim , BH , Hwang , MR , Cho , JR , Kim , HM , Lee , YC , Kim , CH , Kim , JK , Kim , BJ and Choo , YK . 2001 . Differential distribution of ganglioside GM3 in seminiferous tubule and epididymis of adult rats . Arch Pharmacol Res , 24 : 360 – 366 .
   PubMed Web of Science ®Google Scholar
• Kurts , C , Carbone , FR , Krummel , MF , Koch , KM , Miller , JF and Heath , WR . 1999 . Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells . Nature , 398 : 341 – 344 .
   PubMed Web of Science ®Google Scholar
• Latza , U , Foss , HD , Durkop , H , Eitelbach , F , Dieckmann , KP , Loy , V , Unger , M , Pizzolo , G and Stein , H . 1995 . CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule . Am J Pathol , 146 : 463 – 471 .
   PubMed Web of Science ®Google Scholar
• Levi , E , Pfeifer , WM and Kadin , ME . 2001 . CD30‐activation‐mediated growth inhibition of anaplastic large‐cell lymphoma cell lines: apoptosis or cell‐cycle arrest? . Blood , 98 : 1630 – 1632 .
   PubMed Web of Science ®Google Scholar
• Mechtersheimer , G and Moller , P . 1990 . Expression of Ki‐1 antigen (CD30) in mesenchymal tumors . Cancer , 66 : 1732 – 1737 .
   PubMed Web of Science ®Google Scholar
• Meehan , T , Schlatt , S , O'Bryan , MK , de Kretser , DM and Loveland , KL . 2000 . Regulation of germ cell and Sertoli cell development by activin, follistatin, and FSH . Dev Biol , 220 : 225 – 237 .
   PubMed Web of Science ®Google Scholar
• Meng , X , Lindahl , M , Hyvonen , ME , Parvinen , M , de Rooij , DG , Hess , MW , Raatikainen‐Ahokas , A , Sainio , K , Rauvala , H , Lakso , M , Pichel , JG , Westphal , H , Saarma , M and Sariola , H . 2000 . Regulation of cell fate decision of undifferentiated spermatogonia by GDNF . Science , 287 : 1489 – 1493 .
   PubMed Web of Science ®Google Scholar
• Opat , S and Gaston , JS . 2000 . CD30:CD30 ligand interactions in the immune response . Autoimmunity , 33 : 45 – 60 .
   PubMed Web of Science ®Google Scholar
• Pallesen , G and Hamilton‐Dutoit , SJ . 1988 . Ki‐1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma . Am J Pathol , 133 : 446 – 450 .
   PubMed Web of Science ®Google Scholar
• Papadopoulos , N , Galazios , G , Anastasiadis , P , Kotini , A , Stellos , K , Petrakis , G , Zografou , G , Polihronidis , A and Tamiolakis , D . 2001 . Human decidual cells can express the Hodgkin's cell‐associated antigen Ki‐1 (CD30) in spontaneous abortions during the first trimester of gestation . Clin Exp Obstet Gynecol , 28 : 225 – 228 .
   PubMedGoogle Scholar
• Paulli , M , Berti , E , Rosso , R , Boveri , E , Kindl , S , Klersy , C , Lazzarino , M , Borroni , G , Menestrina , F Santucci , M . 1995 . CD30/Ki‐1‐positive lymphoproliferative disorders of the skin‐clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cutaneous Lymphoma Project Group . J Clin Oncol , 13 : 1343 – 1354 .
   PubMed Web of Science ®Google Scholar
• Pera , MF , Bennett , W and Cerretti , DP . 1998 . CD30 and its ligand: possible role in regulation of teratoma stem cells . Apmis , 106 : 169 – 172 . discussion 173
   PubMed Web of Science ®Google Scholar
• Piris , M , Brown , DC , Gatter , KC and Mason , DY . 1990 . CD30 expression in non‐Hodgkin's lymphoma . Histopathology , 17 : 211 – 218 .
   PubMed Web of Science ®Google Scholar
• Rivarola , MA , Sanchez , P and Saez , JM . 1985 . Stimulation of ribonucleic acid and deoxyribonucleic acid synthesis in spermatogenic cells by their coculture with Sertoli cells . Endocrinology , 117 : 1796 – 1802 .
   PubMed Web of Science ®Google Scholar
• Romagnani , S , Del Prete , G , Maggi , E , Chilosi , M , Caligaris‐Cappio , F and Pizzolo , G . 1995 . CD30 and type 2 T helper (Th2) responses . J Leukocyte Biol , 57 : 726 – 730 .
   PubMed Web of Science ®Google Scholar
• Romagnani , S . 1995 . Role for CD30 antigen in human T helper 2‐type responses . Ciba Found Symp , 195 : 55 – 67 .
   PubMedGoogle Scholar
• Romagnani , S . 1996 . Th1 and Th2 in human diseases . Clin Immunol Immunopathol , 80 : 225 – 235 .
   PubMedGoogle Scholar
• Romagnani , S , Parronchi , P , D'Elios , MM , Romagnani , P , Annunziato , F , Piccinni , MP , Manetti , R , Sampognaro , S , Mavilia , C , De Carli , M , Maggi , E and Del Prete , GF . 1997 . An update on human Th1 and Th2 cells . Int Arch Allergy Immunol , 113 : 153 – 156 .
   PubMed Web of Science ®Google Scholar
• Schwab , U , Stein , H , Gerdes , J , Lemke , H , Kirchner , H , Schaadt , M and Diehl , V . 1982 . Production of a monoclonal antibody specific for Hodgkin and Sternberg‐Reed cells of Hodgkin's disease and a subset of normal lymphoid cells . Nature , 299 : 65 – 67 .
   PubMed Web of Science ®Google Scholar
• Smith , CA , Davis , T , Anderson , D , Solam , L , Beckmann , MP , Jerzy , R , Dower , SK , Cosman , D and Goodwin , RG . 1990 . A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins . Science , 248 : 1019 – 1023 .
   PubMed Web of Science ®Google Scholar
• Telford , WG , Nam , SY , Podack , ER and Miller , RA . 1997 . CD30‐regulated apoptosis in murine CD8 T cells after cessation of TCR signals . Cell Immunol , 182 : 125 – 136 .
   PubMed Web of Science ®Google Scholar
• Willers , J , Dummer , R , Kempf , W , Kundig , T , Burg , G and Kadin , ME . 2003 . Proliferation of CD30+ T‐helper 2 lymphoma cells can be inhibited by CD30 receptor cross‐linking with recombinant CD30 ligand . Clin Cancer Res , 9 : 2744 – 2754 .
   PubMed Web of Science ®Google Scholar
• To whom correspondence should be addressed. Tel: 82–63–220–2518, Fax: 82–63–220–2054 E‐mail: [email protected]
   Google Scholar